U.S. MARKET ACCESS
F3 IndBio Landing
U.S. market entry for agricultural and industrial biotechnology. A company-led landing platform for international companies that need a temporary Maryland base and a practical pathway to U.S. customers, partners, manufacturing, and longer-term operations.
Before committing to a permanent facility, team, manufacturing relationship, or major capital investment, an international company may need to validate technical performance, understand U.S. regulatory and testing requirements, identify customers and partners, evaluate manufacturing options, and determine where a longer-term U.S. operation should be established.
F3 IndBio Landing gives international agricultural and industrial biotechnology companies a controlled way to answer those questions before making the larger U.S. investment.
Bring your technology and your team. Use F3 Tech as a temporary U.S. technical and commercialization base while you determine what must be proven, adapted, validated, regulated, or connected for successful U.S. market entry. The company remains in control of its science, intellectual property, technical decisions, and U.S. strategy; F3 Tech provides access to the operating environment, infrastructure, specialized resources, market-entry relationships, and engagement formats appropriate to the work.
Generate U.S.-based technical, analytical, field, or independent third-party evidence.
Clarify the likely U.S. regulatory pathway and connect with qualified specialists for FDA, USDA, EPA, or other applicable requirements.
Refine process, product, specifications, documentation, or workflows for U.S. requirements.
Build relationships with customers, distributors, regulatory specialists, partners, universities, and manufacturers.
Use focused technical access, testing, scale-readiness work, and commercialization support to reach the next milestone.
Determine whether and how to establish a longer-term Maryland/U.S. presence.
Complete the F3 Tech Advancement Readiness Assessment. Tell us where the technology stands, the U.S. objective, required capabilities, timing, funding, team availability, facility/safety considerations, likely regulatory questions, and what evidence or relationships would move the company forward.
F3 Tech reviews technical fit, facility and biosafety requirements, U.S. market-entry readiness, likely regulatory-resource needs, timing, and partner requirements. Together we define the engagement format, reserved capabilities, technical work, third-party testing, regulatory-support connections, market-entry priorities, and any optional support.
Company personnel use F3 Tech as a temporary U.S. technical and operating base. Work may combine company-led facility use, separately scoped F3 technical services, independent testing, regulatory consultations through qualified specialists, field/agricultural validation, and introductions to relevant U.S. resources.
Use the evidence, regulatory clarity, and relationships generated through the engagement to make the next decision: additional development, manufacturing, customer validation, agency engagement, capital, partnership formation, or a longer-term Maryland/U.S. presence.
Concentrated, scheduled access for focused runs, analytical work, setup, troubleshooting, a defined technical question, or generation of evidence needed for a regulatory or customer discussion.
Reserved short-term access for repeated runs, optimization, validation, technical advancement, U.S.-based evidence generation, and market-entry work.
Longer-duration access can be considered when a company needs an ongoing Maryland presence while completing technical, regulatory, validation, and market-entry work.
Access F3 Tech’s 10L bioprocessing capabilities for qualified fermentation, optimization, repeatability and scale-readiness work.
Use F3 Tech’s separate analytical testing laboratory and appropriate LC-MS and SPR capabilities to generate data supporting technical and commercialization decisions.
Extend the project through qualified third-party analytical and testing resources, including Eurofins when appropriate.
Connect with qualified U.S. regulatory specialists and relevant Maryland/Washington resources to clarify likely pathways, evidence needs and market-entry requirements.
Access qualified regional partners for appropriate field, crop, greenhouse or application validation when project needs and partner availability align.
When work needs to move beyond F3 Tech’s current capabilities, identify appropriate CDMOs, manufacturers and other scale-up resources.
Connect with appropriate specialists and organizations for legal, IP, immigration, accounting, business formation, customers, distribution, workforce, capital and partnerships.
Use F3 Tech as a practical Maryland base for technical work, meetings, partner engagement and evaluation of longer-term U.S. opportunities.
F3 Tech is intentionally focused on agricultural and industrial biotechnology—sometimes referred to as green and white biotechnology. This includes companies whose U.S. market-entry questions involve making, testing, validating, regulating or scaling biological products and processes outside traditional clinical biopharma.
WHY MARYLAND?
Use Maryland as a base for reaching customers, partners and markets across the Mid-Atlantic and East Coast.
Operate within regional reach of USDA, FDA, EPA and the broader Washington regulatory and scientific ecosystem.
Connect into a region where biotechnology capabilities intersect with agriculture, research, testing and manufacturing resources.
Test the market through F3 Tech before deciding whether Maryland should become your company’s longer-term U.S. home.
For an international agricultural or industrial biotechnology company, product classification, agency jurisdiction, import rules, testing expectations, registrations, permits and other requirements can materially affect the U.S. development and commercialization plan.
F3 Tech’s Maryland location provides regional access to the federal regulatory and scientific ecosystem in Maryland and Washington, D.C. F3 Tech can help companies identify the right questions, connect with qualified U.S. regulatory specialists, align testing with defined evidence needs, and prepare for appropriate engagement with relevant agencies.
ADDITIONAL MARYLAND RESOURCE
Eligible foreign companies may also be able to participate in the Maryland Global Gateway Soft Landing Program, which is designed to help qualified companies physically test the U.S. market through Maryland partner organizations and may provide additional market-entry support. Eligibility, placement, benefits, funding and program terms are determined by Maryland Commerce and may change. F3 IndBio Landing participation does not guarantee Global Gateway acceptance or funding.
If your project requires your team to spend time at F3 Tech, we understand that travel, lodging, and local transportation become part of the project economics. F3 Tech can help visiting teams identify practical options for getting to Easton, staying locally, and getting around during their engagement—whether you are here for a focused capability campaign or a longer period of onsite work.
Start by telling us what you are developing, what you need to accomplish in the United States, and what capabilities or relationships may be required.
No commitment required. The assessment takes approximately 5–10 minutes.
